TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: change in daily calcium intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: time of recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: BUN decrease rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Scr decrease rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: KT/V
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Progressive disease rate
Endpoint domain: Mortality/survival
Primary endpoint: Number of regular medicines deprescribed per patient
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: range of motion (ROM) in the affected knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to multifaceted podiatry intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of paraesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: reduction in probing depth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increased area of keratinized tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ASDAS‐MI achievement at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Granzyme B content of CD8 cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time to bowel movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mean time to readiness for surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness of block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ocular akinesia rating by surgeons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: total eye symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: symptom medication scores
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: lower-limb motor function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of inhibin B (INHB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Concentration of follicle-stimulating hormone (FSH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Concentration of leuteinizing hormone (LH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in seizure frequency of > or =50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Executive function z-scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients reaching primary end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median time to reach primary end point
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pa(O(2))/Fi(O(2)) value > 315
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global caesarean section risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: total number of recurrences
Endpoint domain: Mortality/survival
Primary endpoint: recurrence-free outcome
Endpoint domain: Mortality/survival
Primary endpoint: incidence of postdural puncture headache
Endpoint domain: Adverse events/effects
Primary endpoint: spinal anesthesia failure rate
Endpoint domain: Adverse events/effects
Primary endpoint: Post-ESD bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prostate cancer progression
Endpoint domain: Mortality/survival
Primary endpoint: 100% cumulative lesion clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: 100% target lesion clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Trough serum levels of lansoprazole, ranitidine, and clarithromycin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under curve of ranitidine, clarithromycin, and amoxycillin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgeon's mental stress load
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Overall hospital costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Correct performance of manual chest compressions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of anal spasm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of anal fissure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median visual analogue scale score
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Clinical response at weeks 8 and 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission at week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: probability of respiratory deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Tear film evaporation rate (TER)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MNA changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PGA score of clear-almost clear
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean nightly adherence to CPAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decrease in Epworth Sleepiness Scale score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: time to block suitable for surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: verbal numeric pain scores at abdominal opening and at child birth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: return to unrestricted daily activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Re-epithelialization speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of children experiencing ≥1 AOM episode
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Number of children who developed uncomplicated AOM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: mean failure load
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stiffness of the stabilized odontoid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: grade 2/3 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Serum C-reactive protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall sinus symptom assessment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weighted average of sinus symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of successful ETI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to successful ETI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in tinnitus-specific variables
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vitreous Opacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ulceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: abundance of Lactobacillus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants affected by cold
Endpoint domain: Adverse events/effects
Primary endpoint: Severity of symptoms at episode start
Endpoint domain: Adverse events/effects
Primary endpoint: Back pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: NSAID induced ulcer relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: mobilized CD34+ cells/μL in peripheral blood
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: number of CD34+ cells/kg body weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: voice handicap
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Horner's syndrome occurrence
Endpoint domain: Adverse events/effects
Primary endpoint: ventral spread
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cephalad spread
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daytime dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: initial period of hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Plasma total and LDL cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in overall therapies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in number of shocks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Parental attribution of success in managing child's behavior
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ratings of attractiveness of facial stimuli
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of Exercise-Induced Asthma (EIA) measured as % fall in FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Requirement for platelet transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total number of platelet transfusions required
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Time to platelet recovery to more than 50,000/microL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Intervention uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Fidelity of intervention delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deaths from external causes
Endpoint domain: Mortality/survival
Primary endpoint: perceptual aberrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: delusion-like beliefs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Dipyridamole time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Global Radial Strain (GRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 25OHD2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: total 25OHD levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean seizure frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of patients seizure free
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of blood glucose testing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: number of inpatient admissions
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Accelerometric parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrarenal vasodilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: reduced sweating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower procedure-related pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: higher patient satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccine-homologous HI response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Heterologous HI response against A/Vietnam/1194/2004 strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: clinically unpredictable movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in symptoms and functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean costs for the index episode
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum cortisol increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Patient preference for injection method
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: B‐Au
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Mean wall thickness of trabecular and endosteal hemiosteons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: IGF‐II immunoreactive staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bone reabsorption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: osteo-integrative process
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: sphincter of Oddi baseline pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: phasic sphincter contraction amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: IADL functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: self-perception of health status
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Annual incidence of invasive breast cancer
Endpoint domain: Mortality/survival
Primary endpoint: Annual incidence of invasive plus noninvasive breast cancers
Endpoint domain: Mortality/survival
Primary endpoint: Mean IOP difference between PPPT and GT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preference for PPPT over GT
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Coefficient of repeatability between PPPT and GT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacteriologic cure of infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SGRQ impact subscale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Advance Care Planning (ACP) choices
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: serum DHA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement in overall cognitive deficits
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: immediate memory index score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: delayed memory index score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: nephrolithiasis risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Proportion of subjects with asthma control
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in inhaled corticosteroid therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevention of depressive disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental Component Summary score improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Mental Health Inventory improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Pain Effects Scale improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceived Deficits Questionnaire improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: skin surface temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Implicit attitudes towards smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Explicit attitudes towards smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: spiritual quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Olfactory acuity improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of perceived participation restriction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean visual acuity (logMAR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean intraocular pressure (mm Hg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient productivity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Patient well-being
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: state depressed affect
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 6-month percent change in weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Predose Trx‐1 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: less infection at the fracture site
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Disease free survival (DFS) at 5 years
Endpoint domain: Mortality/survival
Primary endpoint: Gastrointestinal damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Ratings of perceived exertion
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: weight loss at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy of IANB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LTE(4)-related albuterol usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Creatine kinase (CK)-MB levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients repeating a suicide attempt
Endpoint domain: Mortality/survival
Primary endpoint: Total number of suicide attempts
Endpoint domain: Mortality/survival
Primary endpoint: slowing radiological progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in the number of medications prescribed that were requested
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher medication adherence at 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Left ventricular hypertrophy (LVH) regression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of second primary cancers
Endpoint domain: Mortality/survival
Primary endpoint: Recurrence of first tumor
Endpoint domain: Mortality/survival
Primary endpoint: FEV1 percentage change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Satiation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Withdrawals because of lack of response
Endpoint domain: Adverse events/effects
Primary endpoint: Decrease in depersonalisation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in dedication
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Increase in mindfulness skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: perceived control over ejaculation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Decline in depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: hand tremor improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of treatment for childhood overweight and obesity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Estimated cumulative kidney doses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Concentration of C-peptide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Numbers of T lymphocyte subpopulations (CD2, CD4, CD8)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Survival time of grafts
Endpoint domain: Mortality/survival
Primary endpoint: Fraud and low uptake
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: NPRQ levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analog scale scores for pain at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes